author-photo

J. Rau

University of Marburg

16

Papers

1239

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer

2019 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (23)
Treating prolonged grief disorder with prolonged grief-specific cognitive behavioral therapy: study protocol for a randomized controlled trial

2018 Trials
Show All
- Source
- Cite
- Save
Citations (17)
Behavioural outcomes of subthalamic stimulation and medical therapy versus medical therapy alone for Parkinson's disease with early motor complications (EARLYSTIM trial): secondary analysis of an open-label randomised trial

2018 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (64)
Myths and facts about the EARLYSTIM study

2014 Movement Disorders
Show All
- Source
- Cite
- Save
Citations (33)
Die AGO-OVAR 2.20/PENELOPE Studie – Therapie des platinresistenten Ovarialkarzinoms mit Pertuzumab (P) und Chemotherapie (CT) nach Biomarker-unterstützter Präselektion von Patienten

2014 Geburtshilfe Und Frauenheilkunde
Show All
- Source
- Cite
- Save
Citations (0)
Neurostimulation for Parkinson's Disease with Early Motor Complications

2013 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (869)
Stimulation of the subthalamic nucleus at an earlier disease stage of Parkinson's disease: Concept and standards of the EARLYSTIM-study

2013 Parkinsonism & Related Disorders
Show All
- Source
- Cite
- Save
Citations (98)
Randomized phase II trial of carboplatin and paclitaxel with or without lonafarnib in first-line treatment of epithelial ovarian cancer stage IIB-IV

2012 Gynecologic Oncology
Show All
- Source
- Cite
- Save
Citations (22)
A phase II trial (AGO 2.11) in platinum-resistant ovarian cancer: a randomized multicenter trial with sunitinib (SU11248) to evaluate dosage, schedule, tolerability, toxicity and effectiveness of a multitargeted receptor tyrosine kinase inhibitor monotherapy

2012 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (64)